People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Other Health Care, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synchroneuron Inc. | — | Other Health Care | Seed | $5.5M | $86.8M | 2014 |
| Ternus Pharma, Inc. | — | Pharmaceuticals | Pre-Seed | $185K | $8.8M | 2016 |
MARC R. COTE at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside MARC R. COTE on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William D. Kerns | 2 | 2 |
| Isaac S. Cheng | 1 | 2 |
| BARRY S. FOGEL | 1 | 2 |
| Gerald S. Chan | 1 | 1 |
| Marc S. Cote | 1 | 1 |
| Sundeep R. Dugar | 1 | 1 |
| GERALD R. CHAN | 1 | 1 |
| Dhiren D. Thakker | 1 | 1 |
| ISAAC R. CHENG | 1 | 1 |
| WILLLIAM D. KERNS | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.